Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/19/2025

Management of Pregnant Patients with Multiple Comorbidities

Hypertension Management

  • The American College of Cardiology recommends initiating antihypertensive medication immediately in pregnant patients with blood pressure ≥140/90 mmHg, particularly those with a history of gestational hypertension and pre-eclampsia 1, 2
  • Target diastolic BP of 85 mmHg and systolic BP between 110-140 mmHg to ensure adequate uteroplacental perfusion 1, 2
  • First-line agents for hypertension management in pregnancy include oral methyldopa, labetalol, or nifedipine, as recommended by the European Society of Cardiology 3, 1, 2
  • The American Heart Association recommends discontinuing propranolol due to its association with fetal growth retardation when used long-term during pregnancy 3
  • Labetalol is the preferred beta-blocker for anxiety/hypertension in pregnancy, as recommended by the European Society of Cardiology 3, 1

Urinary Tract Infection Treatment

  • The European Society of Cardiology recommends obtaining urine culture immediately and initiating empiric antibiotic therapy in pregnant patients with suspected UTI 3
  • Safe antibiotics in pregnancy include nitrofurantoin, amoxicillin-clavulanate, or cephalexin, as recommended by the European Society of Cardiology 3

Seizure Disorder Management

  • The American Academy of Family Physicians recommends increasing folic acid supplementation to 4 mg daily in pregnant patients taking antiepileptic drugs, such as levetiracetam, to reduce neural tube defect risk 4

ITP Management

  • The American Society of Hematology recommends obtaining baseline platelet count immediately and monitoring platelet counts monthly in the first and second trimesters, and every 2 weeks in the third trimester 5, 6
  • No treatment is needed if platelet count remains ≥20-30 × 10⁹/L and patient is asymptomatic throughout the first two trimesters, as recommended by the American Society of Hematology 5, 6, 7
  • Treatment is indicated if patient becomes symptomatic with bleeding, platelet count falls below 20-30 × 10⁹/L, or procedures are planned, as recommended by the American Society of Hematology 5, 6
  • Target platelet count ≥50 × 10⁹/L for vaginal delivery or cesarean section, and ≥75 × 10⁹/L if epidural/spinal anesthesia is desired, as recommended by the American Society of Hematology 5, 6, 7

Pre-eclampsia Risk Management

  • The American College of Cardiology recommends considering low-dose aspirin prophylaxis in pregnant patients with a history of early-onset pre-eclampsia, although evidence is mixed 3
  • Monitor for proteinuria at every visit, and obtain 24-hour urine collection or protein/creatinine ratio if dipstick shows ≥1+ protein, as recommended by the American College of Cardiology 3, 1, 2
  • BP ≥170/110 mmHg is a hypertensive emergency requiring hospitalization, as recommended by the American College of Cardiology 3, 1

Multidisciplinary Coordination

  • Establish a care team including an obstetrician experienced in high-risk pregnancy, hematologist, neurologist, and obstetric anesthetist, as recommended by the American Society of Hematology 5, 6, 7

Breastfeeding Considerations

  • Most antihypertensives are compatible with breastfeeding, though specific agent selection should consider this, as recommended by the American College of Cardiology 1
  • Sertraline has relatively low breast milk transfer and is generally considered compatible with breastfeeding, as recommended by the European Society of Cardiology 3

Key Pitfalls to Avoid

  • Do not use atenolol or propranolol long-term due to their association with fetal growth restriction, as recommended by the European Society of Cardiology 3
  • Do not withhold antihypertensive treatment, as untreated hypertension ≥140/90 mmHg increases maternal and fetal morbidity, as recommended by the American College of Cardiology 1, 2
  • Do not delay ITP treatment if platelets fall or bleeding occurs, as maternal hemorrhage risk increases significantly, as recommended by the American Society of Hematology 5, 6
  • Do not discontinue levetiracetam without neurology consultation, as seizures during pregnancy pose greater risk than medication exposure, as recommended by the American Academy of Family Physicians 4